Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Ratanatharathorn, V' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 64 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jacobson, P; Ng, J; Ratanatharathorn, V; Uberti, J; Brundage, RC
      Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients

      BONE MARROW TRANSPLANTATION
    2. Ratanatharathorn, V; Ayash, L; Lazarus, HM; Fu, J; Uberti, JP
      Chronic graft-versus-host disease: clinical manifestation and therapy

      BONE MARROW TRANSPLANTATION
    3. Ayash, LJ; Clarke, M; Silver, SM; Braun, T; Uberti, J; Ratanatharathorn, V; Reynolds, C; Ferrara, J; Broun, ER; Adams, PT
      Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review

      BONE MARROW TRANSPLANTATION
    4. Reynolds, C; Ratanatharathorn, V; Adams, P; Braun, T; Silver, S; Ayash, L; Carson, E; Eisbruch, A; Dawson, LA; McDonagh, K; Ferrara, J; Uberti, J
      Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma

      BONE MARROW TRANSPLANTATION
    5. Ratanatharathorn, V; Lorvidhaya, V; Maoleekoonpairoj, S; Phromratanapongse, P; Sirilerttrakul, S; Kraipiboon, P; Cheirsilpa, A; Tangkaratt, S; Srimuninnimit, V; Pattaranutaporn, P
      Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

      LUNG CANCER
    6. Hanna, E; Shrieve, DC; Ratanatharathorn, V; Xia, XQ; Breau, R; Suen, J; Lil, SL
      A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck

      CANCER RESEARCH
    7. Kollman, C; Howe, CWS; Anasetti, C; Antin, JH; Davies, SM; Filipovich, AH; Hegland, J; Kamani, N; Kernan, NA; King, R; Ratanatharathorn, V; Weisdorf, D; Confer, DL
      Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

      BLOOD
    8. Ratanatharathorn, V; Ferrara, JLM
      Hemopoietic stem cell transplantation

      THERAPEUTIC IMMUNOLOGY, SECOND EDITION
    9. Ratanatharathorn, V; Powers, WE; Moss, WT; Perez, C
      Bone metastases: Ongoing controversies in fractionation schedules - Response to letter to the editor from Dr. Jackson Wu and Dr. Andrea Bezjak

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    10. Ratanatharathorn, V; Powers, WE; Moss, WT; Perez, CA
      Fractionated radiotherapy for metastatic bone pain: Evidence-based medicine or ... ? - Response

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    11. Ratanatharathorn, V; Powers, WE; Moss, WT; Perez, C
      Bone metastasis: Review and critical analysis of random allocation trial of local field treatment: Regarding Ratanatharathorn ET AL-IJROB 44(1): 1-18; 1999 - Response

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    12. Yanik, G; Levine, JE; Ratanatharathorn, V; Dunn, R; Ferrara, J; Hutchinson, RJ
      Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation

      BONE MARROW TRANSPLANTATION
    13. Cronin, S; Uberti, JP; Ayash, LJ; Raith, C; Ratanatharathorn, V
      Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    14. Sirisriro, R; Boonkitticharoen, V; Kraiphibul, P; Ratanatharathorn, V; Sumboonnanon, K; Kanjanapitak, A; Kuhapremma, T; Sritara, C; Puchinda, D; Chouplywech, P; Jalayondeja, V; Pekanan, P; Rochanawutanon, M; Intaramarn, C; Ayudhya, ANN; Chokesuwathana, P
      Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with Tc-99m scintigraphy

      HEPATO-GASTROENTEROLOGY
    15. Ungkanont, A; Jootar, S; Ratanatharathorn, V; Chiernsilp, A
      High dose chemotherapy and peripheral blood stem cell transplantation for high risk primary breast cancer: A single center experience in Thailand

      ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY
    16. Nash, RA; Antin, JH; Karanes, C; Fay, JW; Avalos, BR; Yeager, AM; Przepiorka, D; Davies, S; Petersen, FB; Bartels, P; Buell, D; Fitzsimmons, W; Anasetti, C; Storb, R; Ratanatharathorn, V
      Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

      BLOOD
    17. Ratanatharathorn, V; Carson, E; Reynolds, C; Ayash, LJ; Levine, J; Yanik, G; Silver, SM; Ferrara, JLM; Uberti, JP
      Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

      ANNALS OF INTERNAL MEDICINE
    18. Uberti, JP; Cronin, S; Ratanatharathorn, V
      Optimum use of tacrolimus in the prophylaxis of graft versus host disease

      BIODRUGS
    19. Ratanatharathorn, V; Powers, WE; Moss, WT; Perez, CA
      Bone metastasis: Review and critical analysis of random allocation trials of local field treatment

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    20. Laohavinij, S; Maoleekoonpairoj, S; Cheirsilpa, A; Maneechavakajorn, J; Sirachainant, E; Arpornvivat, W; Jaisathaporn, K; Ratanatharathorn, V
      Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer

      LUNG CANCER
    21. CHOI D; PERRIN M; HOFFMANN S; CHANG AE; RATANATHARATHORN V; UBERTI J; MCDONAGH KT; MULE JJ
      DENDRITIC CELL-BASED VACCINES IN THE SETTING OF PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - CD34(-DEPLETED MOBILIZED PERIPHERAL-BLOOD CAN SERVE AS A SOURCE OF POTENT DENDRITIC CELLS() CELL)

      Clinical cancer research
    22. JACOBSON P; UBERTI J; DAVIS W; RATANATHARATHORN V
      TACROLIMUS - A NEW AGENT FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN HEMATOPOIETIC STEM-CELL TRANSPLANTATION

      Bone marrow transplantation
    23. VISUTHIKOSOL V; KRUAVIT A; NITIYANANT P; POCHANUGOOL L; RATANATHARATHORN V
      SALVAGE TREATMENT FOR SARCOMAS OF THE HAND

      Annals of plastic surgery
    24. RATANATHARATHORN V; NASH RA; PRZEPIORKA D; DEVINE SM; KLEIN JL; WEISDORF D; FAY JW; NADEMANEE A; ANTIN JH; CHRISTIANSEN NP; VANDERJAGT R; HERZIG RH; LITZOW MR; WOLFF SN; LONGO WL; PETERSEN FB; KARANES C; AVALOS B; STORB R; BUELL DN; MAHER RM; FITZSIMMONS WE; WINGARD JR
      PHASE-III STUDY COMPARING METHOTREXATE AND TACROLIMUS (PROGRAF, FK506) WITH METHOTREXATE AND CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION

      Blood
    25. PRZEPIORKA D; PHILLIPS GL; RATANATHARATHORN V; COTTLERFOX M; SEHN LH; ANTIN JH; LEBHERZ D; AWWAD M; HOPE J; MCCLAIN JB
      A PHASE-II STUDY OF BTI-322, A MONOCLONAL ANTI-CD2 ANTIBODY, FOR TREATMENT OF STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE

      Blood
    26. VARTERASIAN M; JANAKIRAMAN N; KARANES C; ABELLA E; UBERTI J; DRAGOVIC J; RAMAN SBK; ALKATIB A; DU W; SILVER SM; ADAMS PT; SENSENBRENNER L; RATANATHARATHORN V
      TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA - A MULTICENTER COMPARATIVE-ANALYSIS OF PERIPHERAL-BLOOD STEM-CELL AND ALLOGENEIC TRANSPLANT

      American journal of clinical oncology
    27. WINGARD JR; NASH RA; RATANATHARATHORN V; FAY JW; KLEIN JL; PRZEPIORKA D; MAHER RM; DEVINE SM; BOSWELL G; BEKERSKY I; FITZSIMMONS W
      LACK OF INTERACTION BETWEEN TACROLIMUS (FK506) AND METHOTREXATE IN BONE-MARROW TRANSPLANT RECIPIENTS

      Bone marrow transplantation
    28. CHANDRASEKAR PH; MOMIN F; KARANES C; ABELLA S; RATANATHARATHORN V; SENSENBRENNER L
      DISSEMINATED TOXOPLASMOSIS IN MARROW RECIPIENTS - A REPORT OF 3 CASESAND A REVIEW OF THE LITERATURE

      Bone marrow transplantation
    29. UBERTI JP; SILVER SM; ADAMS PT; JACOBSON P; SCALZO A; RATANATHARATHORN V
      TACROLIMUS AND METHOTREXATE FOR THE PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

      Bone marrow transplantation
    30. DIGNAN CR; LEVINE J; RATANATHARATHORN V; GREENSON JK
      EVALUATING GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE (GVHD) - WHERE SHOULD WE BIOPSY

      Laboratory investigation
    31. JACOBSON PA; RATANATHARATHORN V; MA M; SCALZO A; WAGNER L; SCHORK MA; SILVER SM; ADAMS PT; UBERTI JP
      ASSOCIATION OF WHOLE-BLOOD TACROLIMUS (TCL) LEVELS WITH ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) AND NEPHROTOXICITY IN ALLOGENEIC MARROW OR BLOOD STEM-CELL TRANSPLANT RECIPIENTS

      Blood
    32. JACOBSON PA; RATANATHARATHORN V; WU Y; BAKER J; LEVINE J; SILVER SM; ADAMS PT; UBERTI JP
      RISK-ADJUSTED DOSE SCHEDULE OF GANCICLOVIR IS EFFECTIVE FOR THE PREVENTION OF CYTOMEGALOVIRUS-INFECTION IN ALLOGENEIC STEM-CELL TRANSPLANT RECIPIENTS

      Blood
    33. UBERTI JP; ADAMS PT; SILVER SM; JACOBSON PM; SCALZO A; HAMMELEF K; AYASH L; RATANATHARATHORN V
      ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (APBSCT) FOR HIGH-RISK HEMATOLOGIC MALIGNANCIES - THE EFFICACY OF TACROLIMUS (TCL) FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)

      Blood
    34. CHOI D; WALSH M; HOFFMANN S; RATANATHARATHORN V; UBERTI J; CHANG A; MCDONAGH KT; MULE JJ
      DENDRITIC CELL-BASED VACCINES IN THE SETTING OF PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - CD34-DEPLETED MOBILIZED PERIPHERAL-BLOOD CAN SERVE AS A SOURCE OF POTENT DENDRITIC CELLS( CELL)

      Blood
    35. NASH RA; ANTIN J; KARANES C; FAY J; AVALOS B; YEAGER AM; PRZEPIORKA D; DAVIES S; PETERSEN F; BUELL D; FITZSIMMONS W; BARTELS P; HANSEN J; ANASETTI C; STORB R; RATANATHARATHORN V
      PHASE-III STUDY COMPARING TACROLIMUS (FK506) WITH CYCLOSPORINE (CSP) FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROWTRANSPLANTATION FROM UNRELATED DONORS

      Blood
    36. UBERTI JP; SILVER SM; ADAMS PT; SCALZO A; RATANATHARATHORN V
      PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE WITH TACROLIMUS IN PATIENTS RECEIVING ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (ALLOPBSCT)

      Blood
    37. RATANATHARATHORN V; NASH RA; DEVINE SM; PRZEPIORKA D; KLEIN JL; WEISDORF DJ; FAY JW; NADEMANEE AP; ANTIN JH; KARANES C; AVALOS BR; CHRISTIANSEN NP; VANDERJAGT RH; HERZIG RH; LITZOW MR; WOLFF SN; LONGO WR; PETERSEN FB; BUELL DN; MAHER RM; FITZSIMMONS WE; WINGARD JR
      PHASE-III STUDY COMPARING TACROLIMUS (PROGRAF(R), FK506) WITH CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE (GVHD) PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION (BMT)

      Blood
    38. WINGARD JR; NASH RA; PRZEPIORKA D; KLEIN JL; WEISDORF DJ; FAY JW; ZHU J; MAHER RM; FITZSIMMONS WE; RATANATHARATHORN V
      RELATIONSHIPS OF TACROLIMUS (PROGRAF(R), FK506) WHOLE-BLOOD CONCENTRATIONS AND EFFICACY AND SAFETY AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION (BMT)

      Blood
    39. VARTERASIAN M; RATANATHARATHORN V; UBERTI JP; KARANES C; ABELLA E; MOMIN F; KASTENSPORTES C; ALKATIB A; LUM L; HEILBRUN LK; SENSENBRENNER LL
      CLINICAL COURSE AND OUTCOME OF PATIENTS WITH HODGKINS-DISEASE WHO PROGRESS AFTER AUTOLOGOUS TRANSPLANTATION

      Leukemia & lymphoma
    40. JIN NR; LUM LG; RATANATHARATHORN V; SENSENBRENNER LL
      ANTI-CD3-ACTIVATED SPLENOCYTES ENHANCE SURVIVAL IN LETHALLY IRRADIATED MICE AFTER TRANSPLANT OF SYNGENEIC HEMATOPOIETIC STEM-CELLS

      Experimental hematology
    41. SHEARER C; CHANDRASEKAR PH; SENSENBRENNER L; RATANATHARATHORN V; KARANES C; MOMIN F; ABELLA S; LUM L; UBERTI J
      PULMONARY NOCARDIOSIS IN A PATIENT WITH A BONE-MARROW TRANSPLANT

      Bone marrow transplantation
    42. VARTERASIAN M; RATANATHARATHORN V; KARANES C; UBERTI J; MOMIN F; ABELLA E; LUM LG; HEILBRUN LK; SENSENBRENNER LL
      BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA - THE WAYNE-STATE EXPERIENCE

      Bone marrow transplantation
    43. SHIBUYA TY; MOMIN F; ABELLA E; JACOBS JR; KARANES C; RATANATHARATHORN V; SENSENBRENNER LL; LUM LG
      SINUS DISEASE IN THE BONE-MARROW TRANSPLANT POPULATION - INCIDENCE, RISK-FACTORS, AND COMPLICATIONS

      Otolaryngology and head and neck surgery
    44. WINGARD JR; NASH RA; RATANATHARATHORN V; FAY JW; KLEIN JL; PRZEPIORKA D; DEVINE SM; FITZSIMMONS WE
      LACK OF INTERACTION BETWEEN TACROLIMUS (FK506) AND METHOTREXATE (MTX)IN BONE-MARROW TRANSPLANT (BMT) RECIPIENTS

      Blood
    45. UBERTI JP; RATANATHARATHORN V; KARANES C; SENSENBRENNER LL
      ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

      Leukemia & lymphoma
    46. CHANDRASEKAR PH; GATNY CM; SENSENBRENNER L; RATANATHARATHORN V; LUM L; KARANES C; UBERTI J; DEPLANQUE M; SCHULTZ K
      THE EFFECT OF FLUCONAZOLE PROPHYLAXIS ON FUNGAL COLONIZATION IN NEUTROPENIC CANCER-PATIENTS

      Journal of antimicrobial chemotherapy
    47. LUM L; BITONTI O; JIN NR; GALOFORO S; WALKER A; LUM C; ABELLA E; BABINGTON R; KARANES C; MOMIN F; UBERTI J; RATANATHARATHORN V; SENSENBRENNER L
      INTRAVENOUS GAMMA-GLOBULIN (IVIG) DOES NOT ALTER IMMUNE PARAMETERS INA RANDOMIZED TRIAL AFTER BONE-MARROW TRANSPLANTATION (BMT)

      Experimental hematology
    48. ALANGADEN G; CHANDRASEKAR PH; BAILEY E; KHALIQ Y; SENSENBRENNER L; RATANATHARATHORN V; KARANES C; DEPLANQUE M; UBERTI J; LUM L
      ANTIFUNGAL PROPHYLAXIS WITH LOW-DOSE FLUCONAZOLE DURING BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    49. SCHULTZ KR; RATANATHARATHORN V; ABELLA E; EISENBREY AB; KARANES C; LUM LG; DEPLANQUE MM; UBERTI JP; RAVINDRANATH Y; SENSENBRENNER LL
      GRAFT FAILURE IN CHILDREN RECEIVING HLA-MISMATCHED MARROW TRANSPLANTSWITH BUSULFAN-CONTAINING REGIMENS

      Bone marrow transplantation
    50. RATANATHARATHORN V; UBERTI J; KARANES C; LUM LG; ABELLA E; DAN ME; HUSSEIN M; SENSENBRENNER LL
      PHASE-I STUDY OF ALPHA-INTERFERON AUGMENTATION OF CYCLOSPORINE-INDUCED GRAFT-VERSUS-HOST DISEASE IN RECIPIENTS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    51. LUM LG; JOSHI ID; SMITH MR; RATANATHARATHORN V; GALOFORO SC; KARANES C; UBERTI JP; SENSENBRENNER LL
      CONSTITUTIVE AND MITOGEN-STIMULATED CYTOKINE MESSENGER-RNA EXPRESSIONBY PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM MOST AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS IS INTACT

      Bone marrow transplantation
    52. LEVEQUE FG; RATANATHARATHORN V; DAN ME; ORVILLE B; COLEMAN DN; TURNER S
      ORAL CYTOMEGALOVIRUS-INFECTION IN AN UNRELATED BONE-MARROW TRANSPLANTATION WITH POSSIBLE MEDIATION BY GRAFT-VERSUS-HOST DISEASE AND THE USEOF CYCLOSPORINA

      Oral surgery, oral medicine, oral pathology
    53. RATANATHARATHORN V; POWERS WE; STEVERSON N; HAN I; AHMAD K; GRIMM J
      BONE METASTASIS FROM CERVICAL-CANCER

      Cancer
    54. RATANATHARATHORN V; UBERTI J; KARANES C; ABELLA E; LUM LG; MOMIN F; CUMMINGS G; SENSENBRENNER LL
      PROSPECTIVE COMPARATIVE TRIAL OF AUTOLOGOUS VERSUS ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA

      Blood
    55. RATANATHARATHORN V; KARANES C; MOMIN F; UBERTI JP; SENSENBRENNER LL; ABELLA E; LUM LG
      PREPARATIVE REGIMES WITHOUT TOTAL-BODY IRRADIATION (TBI) IN THE RECIPIENTS OF UNRELATED DONOR MARROW

      Blood
    56. MOHAMED AN; MACOSKA JA; KALLIONIEMI A; KALLIONIEMI OP; WALDMAN F; RATANATHARATHORN V; WOLMAN SR
      EXTRACHROMOSOMAL GENE AMPLIFICATION IN ACUTE MYELOID-LEUKEMIA - CHARACTERIZATION BY METAPHASE ANALYSIS, COMPARATIVE GENOMIC HYBRIDIZATION, AND SEMIQUANTITATIVE PCR

      Genes, chromosomes & cancer
    57. RATANATHARATHORN V; KARANES C; UBERTI J; ABELLA E; LUM L; SENSENBRENNER L
      PROSPECTIVE COMPARATIVE TRIAL OF ALLOGENEIC VS AUTOLOGOUS BONE-MARROWTRANSPLANTATION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA

      Experimental hematology
    58. RATANATHARATHORN V; UBERTI JP; KARANES C; LUM LG; ABELLA E; SENSENBRENNER LL
      BUSULFAN, ARA-C AND CYCLOPHOSPHAMIDE (BAC) AS PREPARATIVE REGIMEN FORALLOGENIC TRANSPLANTS IN HIGH-RISK MYELOID DISORDERS

      Experimental hematology
    59. LUM LG; JOSHI ID; GALOFORO SC; ABELLA E; KARANES C; RATANATHARATHORN V; SCHULTZ KR; UBERTI JP; SENSENBRENNER LL; LEDBETTER JA; JUNE CH
      COACTIVATION WITH ANTI-CD28 MONOCLONAL-ANTIBODY ENHANCES ANTI-CD3 MONOCLONAL ANTIBODY-INDUCED PROLIFERATION AND IL-2 SYNTHESIS IN T-CELLS FROM AUTOLOGOUS BONE-MARROW TRANSPLANT RECIPIENTS

      Bone marrow transplantation
    60. RAGAN DP; HE TM; MESINA CF; RATANATHARATHORN V
      CT-BASED SIMULATION WITH LASER PATIENT MARKING

      Medical physics
    61. KARANES C; UBERTI JP; RATANATHARATHORN V; LUM L; ABELLA E; MOMIN F; SENSENBRENNER L
      CYCLOPHOSPHAMIDE, VP-16, AND BCNU (CVB) FOR AUTOLOGOUS AND ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT) IN NON-HODGKINS-LYMPHOMA (NHL)

      Blood
    62. UBERTI JP; KARANES C; RATANATHARATHORN V; LUM L; ABELLA E; MOMIN F; SENSENBRENNER L
      BUSULFAN-BASED PREPARATIVE REGIMENS FOR ACUTE MYELOID-LEUKEMIA IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - THE ROLE OF HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) FOR HIGH-RISK PATIENTS

      Blood
    63. LUM LG; JIN NR; GALOFORO SC; RATANATHARATHORN V; SENSENBRENNER LL
      ACTIVATED SPLENOCYTES ENHANCE SURVIVAL AFTER TRANSPLANTATION OF SYNGENEIC HEMATOPOIETIC PROGENITOR CELLS INTO IRRADIATED MICE

      Blood
    64. RATANATHARATHORN V; KARANES C; UBERTI J; LUM LG; DEPLANQUE MM; SCHULTZ KR; CRONIN S; DAN ME; MOHAMED A; HUSSEIN M; SENSENBRENNER LL
      BUSULFAN-BASED REGIMENS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION INPATIENTS WITH MYELODYSPLASTIC SYNDROMES

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/05/20 alle ore 18:32:05